IP Library Granted Patent US 10,981,897
Granted Patent B2
US 10,981,897 · App. 16/399,330 · Granted Apr 20, 2021

Heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds for controlling ectoparasites

Inventors: Paolo Tosatti (Binningen, CH); Jean-Yves Wach (Zurich, CH)
Assignee: Elanco Tiergesundheit AG
C07D405/14A61P33/14C07D401/04C07D401/14C07D403/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,981,897
App. No.
16/399,330
Granted
Apr 20, 2021
Kind
B2
Abstract

The present invention provides compounds of the formula: (I) wherein: X is O or S; Q 1 and Q 2 are independently CR 5 or N, provided at least one of Q 1 and Q 2 is N; Y is a direct bond or CH 2 ; R 1 is H, optionally substituted alkyl, alkenyl, alkynyl, cycloalkylalkyl, benzyl or oxetan-3-yl-CH 2 —; R 2 is optionally substituted phenyl, pyridine, pyrimidine, pyrazine or pyridazine; R 3 is alkyl or haloalkyl; R 4 is optionally substituted pyridine, pyrimidine, pyrazine or pyridazine; R 5 is H, alkyl, haloalkyl, cycloalkyl, alkoxy, alkoxyC(O)— or (alkoxy) 2 CH—; or a salt thereof. The compounds are useful for controlling ectoparasites on animals.

Claims (44)

1. A process for preparing a compound of formula

wherein:

Q 4 and Q 2 are independently CR 5 or N, provided at least one of Q 4 and Q 2 is N;

Y is a direct bond or CH 2 ;

R 4 is H; C 1 -C 6 alkyl optionally substituted with one substituent selected from: CN, CONH 2 , COOH, NO 2 and Si(CH 3 ) 3 ; C 1 -C 6 haloalkyl; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 2 -C 6 alkynyl; C 2 -C 6 haloalkynyl; C 3 -C 4 cycloalkyl-C 1 -C 2 alkyl- wherein the C 3 -C 4 cycloalkyl is optionally substituted with 1 or 2 halo atoms; oxetan-3-yl-CH 2 —; or benzyl optionally substituted with halo or C 1 -C 3 haloalkyl;

R 2 is phenyl, pyridine, pyrimidine, pyrazine or pyridazine, wherein the phenyl, pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one to three substituents, provided the substituent(s) are not on either carbon adjacent to the carbon bonded to the

group, each independently selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 thiohaloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halo, NO 2 , SF 5 , CN, CONH 2 , COOH and C(S)NH 2 ;

R 3 is C 1 -C 3 alkyl or C 1 -C 3 haloalkyl;

R 4 is pyridine, pyrimidine, pyrazine or pyridazine, wherein the pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one substituent selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 3 -C 4 cycloalkyl, halo or hydroxy; and

R 5 is H, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkoxyC(O)— or (C 4 -C 3 alkoxy) 2 CH—;

or a salt thereof;

the process comprising reacting an azole compound of formula (a) with a carboxylic acid of formula (b) to form a compound of formula (I′),

wherein R 1 , R 2 , R 3 , R 4 , Q 1 , and Q 2 are as defined above;

wherein the azole compound of formula (a) is prepared by:

(i) reacting an amine of formula (c) with a substituted azole of formula (d),

wherein LG is a suitable leaving group, and R 1 , R 3 , R 4 , Q 1 , and Q 2 are as defined above; or

(ii) reacting a substituted azole of formula (d) with ammonia to form a substituted azole of formula (e), and subsequently reacting the substituted azole of formula (e) with a compound of formula (f),

wherein LG is a suitable leaving group, and R 1 , R 3 , R 4 , Q 1 , and Q 2 are as defined above.

2. A process for preparing a compound of formula

wherein:

Y is a direct bond or CH 2 ;

R 4 is H; C 1 -C 6 alkyl optionally substituted with one substituent selected from: CN, CONH 2 , COOH, NO 2 and Si(CH 3 ) 3 ; C 1 -C 6 haloalkyl; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 2 -C 6 alkynyl; C 2 -C 6 haloalkynyl; C 3 -C 4 cycloalkyl-C 1 -C 2 alkyl- wherein the C 3 -C 4 cycloalkyl is optionally substituted with 1 or 2 halo atoms; oxetan-3-yl-CH 2 —; or benzyl optionally substituted with halo or C 1 -C 3 haloalkyl;

R 2 is phenyl, pyridine, pyrimidine, pyrazine or pyridazine, wherein the phenyl, pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one to three substituents, provided the substituent(s) are not on either carbon adjacent to the carbon bonded to the

group, each independently selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 thiohaloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halo, NO 2 , SF 5 , CN, CONH 2 , COOH and C(S)NH 2 ;

R 3 is C 1 -C 3 alkyl or C 1 -C 3 haloalkyl;

R 4 is pyridine, pyrimidine, pyrazine or pyridazine, wherein the pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one substituent selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 3 -C 4 cycloalkyl, halo or hydroxy; and

R 5 is H, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkoxyC(O)— or (C 4 -C 3 alkoxy) 2 CH—;

or a salt thereof;

the process comprising reacting an amide of formula (n) with an N,N-dimethylamide dimethyl acetal of formula (g) to a form compound of formula (o) which is subsequently reacted with a substituted hydrazine of formula (j) under acidic conditions to form a compound of formula (I″),

wherein R 1 , R 2 , R 3 , R 4 , R 5 , and Y are as defined above.

3. The process of claim 2 , wherein the compound of formula (I″) is N-[(1S)-1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide or a salt thereof.

4. The process of claim 2 , wherein the compound of formula (I″) is N-[(1S)-1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide.

5. A process for preparing a compound of formula

wherein:

Y is a direct bond or CH 2 ;

R 1 is H; C 1 -C 6 alkyl optionally substituted with one substituent selected from: CN, CONH 2 , COOH, NO 2 and —Si(CH 3 ) 3 ; C 1 -C 6 haloalkyl; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 2 -C 6 alkynyl; C 2 -C 6 haloalkynyl; C 3 -C 4 cycloalkyl-C 1 -C 2 alkyl- wherein the C 3 -C 4 cycloalkyl is optionally substituted with 1 or 2 halo atoms; oxetan-3-yl-CH 2 —; or benzyl optionally substituted with halo or C 1 -C 3 haloalkyl;

R 2 is phenyl, pyridine, pyrimidine, pyrazine or pyridazine, wherein the phenyl, pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one to three substituents, provided the substituent(s) are not on either carbon adjacent to the carbon bonded to the

group, each independently selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 thiohaloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halo, NO 2 , SF 5 , CN, CONH 2 , COOH and C(S)NH 2 ;

R 3 is C 1 -C 3 alkyl or C 1 -C 3 haloalkyl;

R 4 is pyridine, pyrimidine, pyrazine or pyridazine, wherein the pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one substituent selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 3 -C 4 cycloalkyl, halo or hydroxy; and

R 5 is H, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkoxyC(O)— or (C 4 -C 3 alkoxy) 2 CH—;

or a salt thereof;

the process comprising reacting an amidine hydrochloride of formula (q) with an acid of formula (r) to form a compound of formula (t) which is subsequently reacted with a substituted hydrazine of formula (j) under acidic conditions to form a compound of formula (I″),

wherein R 1 , R 2 , R 3 , R 4 , R 5 , and Y are as defined above.

Continuity (3)
Continuation 15556722
Provisional Application 62332004 · May 5, 2016
Related Publication 20190256501A1 · Aug 22, 2019
Cited By (1)
US 12,583,851